Skip to main content
SpringerLink
Log in
Book cover

ECMO-Extracorporeal Life Support in Adults pp 217–235Cite as

Treatment Options for End-Stage Cardiac Failure

  • Chapter
  • First Online:

  • 5600 Accesses

Abstract

Advanced heart failure (HF) and cardiogenic shock are heterogeneous entities. The Interagency Registry for Mechanical Assisted Circulatory Support (INTERMACS) has developed profile levels to better characterize clinical status. Beyond intra-aortic balloon pump (IABP) counterpulsation therapy and venoarterial extracorporeal membrane oxygenation (ECMO), various options have emerged for cardiac assist devices. Advanced HF support alternatives include percutaneous assist devices, short-term devices, and long-term, implantable ventricular assist devices (VADs). This chapter discusses the principles of application for these devices. The gold standard, however, for end-stage heart disease remains cardiac transplantation. With an ever-growing deficit in available donors compared to required organs, assist-device-based bridging strategies and strategic use of these grafts are paramount. Additionally, an approach to mechanical circulatory support (MCS) implantation stratified by INTERMACS profile levels (1–7), based on clinical goals and the required duration of assistance, is suggested.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL et al (2009) INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 28(6):535–541. doi:10.1016/j.healun.2009.02.015

    Article  PubMed  Google Scholar 

  2. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA et al (2013) Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 32(2):141–156. doi:10.1016/j.healun.2012.12.004

    Article  PubMed  Google Scholar 

  3. Kirklin JK, Naftel DC, Stevenson LW, Kormos RL, Pagani FD, Miller MA et al (2008) INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant 27(10):1065–1072. doi:10.1016/j.healun.2008.07.021

    Article  PubMed  Google Scholar 

  4. Holman WL (2012) Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS): what have we learned and what will we learn? Circulation 126(11):1401–1406. doi:10.1161/CIRCULATIONAHA.112.097816

    Article  PubMed  Google Scholar 

  5. Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL (1968) Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 203(2):113–118

    Article  CAS  PubMed  Google Scholar 

  6. Ramanathan K, Farkouh ME, Cosmi JE, French JK, Harkness SM, Džavík V et al (2011) Rapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarction. Am Heart J 162(2):268–275. doi:10.1016/j.ahj.2011.04.025

    Article  PubMed  PubMed Central  Google Scholar 

  7. O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127(4):529–555. doi:10.1161/CIR.0b013e3182742c84

    Article  PubMed  Google Scholar 

  8. Authors/Task Force Members, Steg PG, James SK, Atar D, Badano LP, Lundqvist CB et al (2012) ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J 33(20):2569–2619. doi:10.1093/eurheartj/ehs215

    Article  CAS  PubMed  Google Scholar 

  9. Thiele H, Schuler G, Neumann F-J, Hausleiter J, Olbrich H-G, Schwarz B et al (2012) Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J 163(6):938–945. doi:10.1016/j.ahj.2012.03.012

    Article  PubMed  Google Scholar 

  10. Zeymer U, Hochadel M, Hauptmann K-E, Wiegand K, Schuhmacher B, Brachmann J et al (2013) Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry. Clin Res Cardiol 102(3):223–227. doi:10.1007/s00392-012-0523-4

    Article  PubMed  Google Scholar 

  11. Lauten A, Engström AE, Jung C, Empen K, Erne P, Cook S et al (2013) Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail 6(1):23–30. doi:10.1161/CIRCHEARTFAILURE.112.967224

    Article  PubMed  Google Scholar 

  12. Griffith BP, Anderson MB, Samuels LE, Pae WE, Naka Y, Frazier OH (2013) The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support. J Thorac Cardiovasc Surg 145(2):548–554. doi:10.1016/j.jtcvs.2012.01.067

    Article  PubMed  Google Scholar 

  13. Kapur NK, Jumean MF (2013) Defining the role for percutaneous mechanical circulatory support devices for medically refractory heart failure. Curr Heart Fail Rep. doi:10.1007/s11897-013-0132-1

    PubMed  Google Scholar 

  14. Kummerfeldt CE, Toma A, Badheka AO, Azzam I, Andrews D, Alfonso C, Chaparro SV (2011) Severe hemolytic anemia and acute kidney injury after percutaneous continuous-flow ventricular assistance. Circ Heart Fail 4(6):e20–e22. doi:10.1161/CIRCHEARTFAILURE.111.964023

    Article  PubMed  Google Scholar 

  15. Ranc S, Sibellas F, Green L (2013) Acute intraventricular thrombosis of an impella LP 5.0 device in an ST-elevated myocardial infarction complicated by cardiogenic shock. J Invasive Cardiol 25(1):E1–E3

    PubMed  Google Scholar 

  16. Tanawuttiwat T, Chaparro SV (2013) An unexpected cause of massive hemolysis in percutaneous left ventricular assist device. Cardiovasc Revasc Med 14(1):66–67. doi:10.1016/j.carrev.2012.10.011

    Article  PubMed  Google Scholar 

  17. Kar B, Adkins LE, Civitello AB, Loyalka P, Palanichamy N, Gemmato CJ et al (2006) Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J 33(2):111–115

    PubMed  PubMed Central  Google Scholar 

  18. Ziemba EA, John R (2010) Mechanical circulatory support for bridge to decision: which device and when to decide. J Card Surg 25(4):425–433. doi:10.1111/j.1540-8191.2010.01038.x

    Article  PubMed  Google Scholar 

  19. Tempelhof MW, Klein L, Cotts WG, Benzuly KH, Davidson CJ, Meyers SN, McCarthy PM, Malaisrie CS, McGee EC, Beohar N (2011) Clinical experience and patient outcomes associated with the tanden heart percutaneous transsepital assist device among a heterogeneous patient population. A Saio Journal 57:254–261

    Google Scholar 

  20. Hernandez AF, Grab JD, Gammie JS, O’Brien SM, Hammill BG, Rogers JG et al (2007) A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons’ National Cardiac Database. Circulation 116(6):606–612. doi:10.1161/CIRCULATIONAHA.106.666289

    Article  PubMed  Google Scholar 

  21. Akay MH, Gregoric ID, Radovancevic R, Cohn WE, Frazier OH (2011) Timely use of a CentriMag heart assist device improves survival in postcardiotomy cardiogenic shock. J Card Surg 26(5):548–552. doi:10.1111/j.1540-8191.2011.01305.x

    Article  PubMed  Google Scholar 

  22. John R, Long JW, Massey HT, Griffith BP, Sun BC, Tector AJ et al (2011) Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg 141(4):932–939. doi:10.1016/j.jtcvs.2010.03.046

    Article  PubMed  Google Scholar 

  23. Shuhaiber JH, Jenkins D, Berman M, Parameshwar J, Dhital K, Tsui S, Large SR (2008) The Papworth experience with the Levitronix CentriMag ventricular assist device. J Heart Lung Transplant 27(2):158–164. doi:10.1016/j.healun.2007.10.015

    Article  PubMed  Google Scholar 

  24. Worku B, Pak S-W, van Patten D, Housman B, Uriel N, Colombo P et al (2012) The CentriMag ventricular assist device in acute heart failure refractory to medical management. J Heart Lung Transplant 31(6):611–617. doi:10.1016/j.healun.2011.12.016

    Article  PubMed  Google Scholar 

  25. Takayama H, Naka Y, Kodali SK, Vincent JA, Addonizio LJ, Jorde UP, Williams MR (2012) A novel approach to percutaneous right-ventricular mechanical support. Eur J Cardiothorac Surg 41(2):423–426. doi:10.1016/j.ejcts.2011.05.041

    Article  PubMed  Google Scholar 

  26. Peura JL, Colvin-Adams M, Francis GS, Grady KL, Hoffman TM, Jessup M et al (2012) Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association. Circulation. doi:10.1161/CIR.0b013e3182769a54

    PubMed  Google Scholar 

  27. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI et al (2012) The registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report–2012. J Heart Lung Transplant 31(10):1052–1064. doi:10.1016/j.healun.2012.08.002

    Article  PubMed  Google Scholar 

  28. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D et al (2009) Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361(23):2241–2251. doi:10.1056/NEJMoa0909938

    Article  CAS  PubMed  Google Scholar 

  29. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD et al (2010) Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 55(17):1826–1834. doi:10.1016/j.jacc.2009.12.052

    Article  PubMed  Google Scholar 

  30. Haft J, Armstrong W, Dyke DB, Aaronson KD, Koelling TM, Farrar DJ, Pagani FD (2007) Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation 116(11 Suppl):I8–I15. doi:10.1161/CIRCULATIONAHA.106.677898

    PubMed  Google Scholar 

  31. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ et al (2009) Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 54(4):312–321. doi:10.1016/j.jacc.2009.03.055

    Article  PubMed  Google Scholar 

  32. Slaughter MS, Meyer AL, Birks EJ (2011) Destination therapy with left ventricular assist devices: patient selection and outcomes. Curr Opin Cardiol 26(3):232–236. doi:10.1097/HCO.0b013e328345aff4

    Article  PubMed  Google Scholar 

  33. HeartMate II LVAS, Operating Manual (2007)

    Google Scholar 

  34. Lahpor J, Khaghani A, Hetzer R, Pavie A, Friedrich I, Sander K, Strüber M (2010) European results with a continuous-flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg 37(2):357–361. doi:10.1016/j.ejcts.2009.05.043

    PubMed  Google Scholar 

  35. Deuse T, Schirmer J, Kubik M, Reichenspurner H (2013) Isolated permanent right ventricular assistance using the HVAD continuous-flow pump. Ann Thorac Surg 95(4):1434–1436. doi:10.1016/j.athoracsur.2012.08.090

    Article  PubMed  Google Scholar 

  36. Krabatsch T, Potapov E, Stepanenko A, Schweiger M, Kukucka M, Huebler M et al (2011) Biventricular circulatory support with two miniaturized implantable assist devices. Circulation 124(11 Suppl):S179–S186. doi:10.1161/CIRCULATIONAHA.110.011502

    Article  PubMed  Google Scholar 

  37. Wu L, Weng Y-G, Dong N-G, Krabatsch T, Stepanenko A, Hennig E, Hetzer R (2013) Outcomes of HeartWare Ventricular Assist System support in 141 patients: a single-centre experience. Eur J Cardiothorac Surg 44(1):139–145. doi:10.1093/ejcts/ezs263

    Article  PubMed  Google Scholar 

  38. Aissaoui N, Börgermann J, Gummert J, Morshuis M (2012) HeartWare continuous-flow ventricular assist device thrombosis: the Bad Oeynhausen experience. J Thorac Cardiovasc Surg 143(4):e37–e39. doi:10.1016/j.jtcvs.2011.12.035

    Article  PubMed  Google Scholar 

  39. Siddique A, Wrightson N, Macgowan GA, Schueler S (2013) Device thrombosis in the HeartWare left ventricular assist device. Ann Thorac Surg 95(4):1508. doi:10.1016/j.athoracsur.2012.10.011

  40. Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, Acker MA et al (2012) Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 125(25):3191–3200

    Google Scholar 

  41. Swartz M (2012) HeartWare IFU 1120 pdf, pp 1–104

    Google Scholar 

  42. Boyle AJ, Russell SD, Teuteberg JJ, Slaughter MS, Moazami N, Pagani FD et al (2009) Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant 28(9):881–887. doi:10.1016/j.healun.2009.05.018

    Article  PubMed  Google Scholar 

  43. Menon AK, Götzenich A, Sassmannshausen H, Haushofer M, Autschbach R, Spillner JW (2012) Low stroke rate and few thrombo-embolic events after HeartMate II implantation under mild anticoagulation. Eur J Cardiothorac Surg 42(2):319–323. doi:10.1093/ejcts/ezr312; discussion 323

    Article  PubMed  Google Scholar 

  44. Moazami N, Fukamachi K, Kobayashi M, Smedira NG, Hoercher KJ, Massiello A et al (2013) Axial and centrifugal continuous-flow rotary pumps: a translation from pump mechanics to clinical practice. J Heart Lung Transplant 32(1):1–11. doi:10.1016/j.healun.2012.10.001

    Article  PubMed  Google Scholar 

  45. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W et al (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345(20):1435–1443. doi:10.1056/NEJMoa012175

    Article  CAS  PubMed  Google Scholar 

  46. Grady KL, Warner Stevenson L, Pagani FD, Teuteberg J, Pamboukian SV, Birks E et al (2012) Beyond survival: recommendations from INTERMACS for assessing function and quality of life with mechanical circulatory support. J Heart Lung Transplant 31(11):1158–1164. doi:10.1016/j.healun.2012.08.020

    Article  PubMed  Google Scholar 

  47. John R, Kamdar F, Eckman P, Colvin-Adams M, Boyle A, Shumway S et al (2011) Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices. Ann Thorac Surg 92(5):1593–1599. doi:10.1016/j.athoracsur.2011.06.081; discussion 1599–600

    Article  PubMed  Google Scholar 

  48. Cowger J, Pagani FD, Haft JW, Romano MA, Aaronson KD, Kolias TJ (2010) The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail 3(6):668–674. doi:10.1161/CIRCHEARTFAILURE.109.917765

    Article  PubMed  PubMed Central  Google Scholar 

  49. Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM et al (2013) Pulsatility and the risk of non-surgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circ Heart Fail. doi:10.1161/CIRCHEARTFAILURE.112.000206

    PubMed  Google Scholar 

  50. Islam S, Cevik C, Madonna R, Frandah W, Islam E, Islam S, Nugent K (2013) Left ventricular assist devices and gastrointestinal bleeding: a narrative review of case reports and case series. Clin Cardiol 36(4):190–200. doi:10.1002/clc.22096

    Article  PubMed  Google Scholar 

  51. Morgan JA, Paone G, Nemeh HW, Henry SE, Patel R, Vavra J et al (2012) Gastrointestinal bleeding with the HeartMate II left ventricular assist device. J Heart Lung Transplant 31(7):715–718. doi:10.1016/j.healun.2012.02.015

    Article  PubMed  Google Scholar 

  52. Slaughter MS (2010) Hematologic effects of continuous flow left ventricular assist devices. J Cardiovasc Transl Res 3(6):618–624. doi:10.1007/s12265-010-9222-6

    Article  PubMed  Google Scholar 

  53. Crow S, Chen D, Milano C, Thomas W, Joyce L, Piacentino V et al (2010) Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg 90(4):1263–1269. doi:10.1016/j.athoracsur.2010.04.099; discussion 1269

    Article  PubMed  Google Scholar 

  54. Demirozu ZT, Radovancevic R, Hochman LF, Gregoric ID, Letsou GV, Kar B et al (2011) Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 30(8):849–853. doi:10.1016/j.healun.2011.03.008

    PubMed  Google Scholar 

  55. Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A, Strueber M (2010) Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 3(6):675–681. doi:10.1161/CIRCHEARTFAILURE.109.877597

    Article  PubMed  Google Scholar 

  56. Suarez J, Patel CB, Felker GM, Becker R, Hernandez AF, Rogers JG (2011) Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices. Circ Heart Fail 4(6):779–784. doi:10.1161/CIRCHEARTFAILURE.111.962613

    Article  PubMed  Google Scholar 

  57. Loscalzo J (2012) From clinical observation to mechanism–Heyde’s syndrome. N Engl J Med 367(20):1954–1956. doi:10.1056/NEJMcibr1205363

    Article  CAS  PubMed  Google Scholar 

  58. Dassanayaka S, Slaughter MS, Bartoli CR (2013) Mechanistic pathway(s) of acquired Von Willebrand syndrome with a continuous-flow ventricular assist device. ASAIO J 59(2):123–129. doi:10.1097/MAT.0b013e318283815c

    Article  CAS  PubMed  Google Scholar 

  59. Sharma V, Deo SV, Stulak JM, Durham LA, Daly RC, Park SJ et al (2012) Driveline infections in left ventricular assist devices: implications for destination therapy. Ann Thorac Surg 94(5):1381–1386. doi:10.1016/j.athoracsur.2012.05.074

    Article  PubMed  Google Scholar 

  60. Goldstein DJ, Naftel D, Holman W, Bellumkonda L, Pamboukian SV, Pagani FD, Kirklin J (2012) Continuous-flow devices and percutaneous site infections: clinical outcomes. J Heart Lung Transplant 31(11):1151–1157. doi:10.1016/j.healun.2012.05.004

    Article  PubMed  Google Scholar 

  61. Cowger J, Sundareswaran K, Rogers JG, Park SJ, Pagani FD, Bhat G et al (2013) Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. J Am Coll Cardiol 61(3):313–321. doi:10.1016/j.jacc.2012.09.055

    Article  CAS  PubMed  Google Scholar 

  62. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA et al (2007) Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116(5):497–505. doi:10.1161/CIRCULATIONAHA.107.691972

    Article  PubMed  Google Scholar 

  63. Bonde P, Ku NC, Genovese EA, Bermudez CA, Bhama JK, Ciarleglio MM et al (2012) Model for end-stage liver disease score predicts adverse events related to ventricular assist device therapy. Ann Thorac Surg 93(5):1541–1547. doi:10.1016/j.athoracsur.2012.02.008; discussion 1547–1548

    Article  PubMed  Google Scholar 

  64. Matthews JC, Pagani FD, Haft JW, Koelling TM, Naftel DC, Aaronson KD (2010) Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation 121(2):214–220. doi:10.1161/CIRCULATIONAHA.108.838656

    Article  PubMed  PubMed Central  Google Scholar 

  65. Yang JA, Kato TS, Shulman BP, Takayama H, Farr M, Jorde UP et al (2012) Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the model of end-stage liver disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. J Heart Lung Transplant 31(6):601–610. doi:10.1016/j.healun.2012.02.027

    Article  PubMed  PubMed Central  Google Scholar 

  66. Kato TS, Stevens GR, Jiang J, Christian Schulze P, Gukasyan N, Lippel M et al (2013) Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation. J Heart Lung Transplant 32(3):333–340. doi:10.1016/j.healun.2012.11.026

    Article  PubMed  Google Scholar 

  67. Kutty RS, Parameshwar J, Lewis C, Catarino PA, Sudarshan CD, Jenkins DP et al (2013) Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension. Eur J Cardiothorac. doi:10.1093/ejcts/ezs678

    Google Scholar 

  68. Baumwol J, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, Jansz P, Hayward CS (2011) Right heart failure and “failure to thrive” after left ventricular assist device: clinical predictors and outcomes. J Heart Lung Transplant 30(8):888–895. doi:10.1016/j.healun.2011.03.006

    PubMed  Google Scholar 

  69. Morgan JA, Paone G, Nemeh HW, Murthy R, Williams CT, Lanfear DE et al (2013) Impact of continuous-flow left ventricular assist device support on right ventricular function. J Heart Lung Transplant 32(4):398–403. doi:10.1016/j.healun.2012.12.018

    Article  PubMed  Google Scholar 

  70. Aissaoui N, Morshuis M, Schoenbrodt M, Hakim Meibodi K, Kizner L, Börgermann J, Gummert J (2013) Temporary right ventricular mechanical circulatory support for the management of right ventricular failure in critically ill patients. J Thorac Cardiovasc Surg 146(1):186–191. doi:10.1016/j.jtcvs.2013.01.044

    Article  PubMed  Google Scholar 

  71. Matthews JC, Koelling TM, Pagani FD, Aaronson KD (2008) The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 51(22):2163–2172. doi:10.1016/j.jacc.2008.03.009

    Article  PubMed  PubMed Central  Google Scholar 

  72. Raina A, Seetha Rammohan HR, Gertz ZM, Rame JE, Woo YJ, Kirkpatrick JN (2013) Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters. J Card Fail 19(1):16–24. doi:10.1016/j.cardfail.2012.11.001

    Article  PubMed  Google Scholar 

  73. Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, Massey T, Milano CA, Moazami N, Sundareswaran KS, Farrar DJ, HeartMate II, Investigators C (2010) Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 139(5):1316–1324. doi:10.1016/j.jtcvs.2009.11.020

    Article  PubMed  Google Scholar 

  74. Kasirajan V, Tang DG, Katlaps GJ, Shah KB (2012) The total artificial heart for biventricular heart failure and beyond. Curr Opin Cardiol 27(3):301–307. doi:10.1097/HCO.0b013e32835220c9

    Article  PubMed  Google Scholar 

  75. Copeland JG, Copeland H, Gustafson M, Mineburg N, Covington D, Smith RG, Friedman M (2012) Experience with more than 100 total artificial heart implants. J Thorac Cardiovasc Surg 143(3):727–734. doi:10.1016/j.jtcvs.2011.12.002

    Article  PubMed  Google Scholar 

  76. Copeland JG, Smith RG, Arabia FA, Nolan PE, Sethi GK, Tsau PH et al (2004) Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med 351(9):859–867

    Article  CAS  PubMed  Google Scholar 

  77. Kirsch MEW, Nguyen A, Mastroianni C, Pozzi M, Léger P, Nicolescu M et al (2013) SynCardia temporary total artificial heart as bridge to transplantation: current results at la pitié hospital. Ann Thorac Surg 95(5):1640–1646. doi:10.1016/j.athoracsur.2013.02.036

    Article  PubMed  Google Scholar 

  78. Kalya A, Jaroszewski D, Pajaro O, Scott R, Gopalan R, Kasper D, Arabia F (2013) Role of total artificial heart in the management of heart transplant rejection and retransplantation: case report and review. Clin Transplant 27(4):E348–E350. doi:10.1111/ctr.12146

    Article  PubMed  Google Scholar 

  79. Quader MA, Tang D, Katlaps G, Shah KB, Kasirajan V (2013) Total artificial heart for patients with allograft failure. J Thorac Cardiovasc Surg 145(2):e21–e23. doi:10.1016/j.jtcvs.2012.10.050

    Article  PubMed  Google Scholar 

  80. Ashfaq A, Jaroszewski DE, Pajaro OE, Arabia FA (2013) The role of the total artificial heart in the treatment of post-myocardial infarction ventricular septal defect. J Thorac Cardiovasc Surg 145(2):e25–e26. doi:10.1016/j.jtcvs.2012.11.018

    Article  PubMed  Google Scholar 

  81. Kirsch M, Mazzucotelli J-P, Roussel J-C, Bouchot O, N’loga J, Leprince P et al (2012) Survival after biventricular mechanical circulatory support: does the type of device matter? J Heart Lung Transplant 31(5):501–508. doi:10.1016/j.healun.2011.11.024

    Article  PubMed  Google Scholar 

  82. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al (2009) 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. doi:10.1161/CIRCULATIONAHA.109.192065

    PubMed Central  Google Scholar 

  83. McKelvie RS, Moe GW, Cheung A, Costigan J, Ducharme A, Estrella-Holder E et al (2011) The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol 27(3):319–338. doi:10.1016/j.cjca.2011.03.011

    Article  PubMed  Google Scholar 

  84. Mancini D, Lietz K (2010) Selection of cardiac transplantation candidates in 2010. Circulation 122(2):173–183. doi:10.1161/CIRCULATIONAHA.109.858076

    Article  PubMed  Google Scholar 

  85. Mehra M, Kobashigawa J, Starling RC, Russell S, Uber P, Parameshwar J et al (2006) Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates—2006. J Heart Lung Transplant 25(9):1024–1042

    Article  PubMed  Google Scholar 

  86. McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–1847. doi:10.1093/eurheartj/ehs104

    Article  PubMed  Google Scholar 

  87. Schulze PC, Jiang J, Yang J, Cheema FH, Schaeffle K, Kato TS et al (2013) Preoperative assessment of high-risk candidates to predict survival after heart transplantation. Circ Heart Fail 6(3):527–534. doi:10.1161/CIRCHEARTFAILURE.112.000092

    Article  CAS  PubMed  Google Scholar 

  88. Karamlou T, Gelow J, Diggs BS, Tibayan FA, Mudd JM, Guyton SW et al (2013) Mechanical circulatory support pathways that maximize post-heart transplant survival. Ann Thorac Surg 95(2):480–485. doi:10.1016/j.athoracsur.2012.05.108; discussion 485

    Article  PubMed  Google Scholar 

  89. Attisani M, Centofanti P, La Torre M, Boffini M, Ricci D, Ribezzo M et al (2012) Advanced heart failure in critical patients (INTERMACS 1 and 2 levels): ventricular assist devices or emergency transplantation? Interact Cardiovasc Thorac Surg 15(4):678–684. doi:10.1093/icvts/ivs256

    Article  PubMed  PubMed Central  Google Scholar 

  90. Barge-Caballero E, Segovia-Cubero J, Almenar-Bonet L, Gonzalez-Vilchez F, Villa-Arranz A, Delgado-Jimenez J et al (2013) Preoperative INTERMACS profiles determine postoperative outcomes in critically Ill patients undergoing emergency heart transplantation: analysis of the Spanish National Heart Transplant Registry. Circ Heart Fail 6(4):763–772. doi:10.1161/CIRCHEARTFAILURE.112.000237

    Article  PubMed  Google Scholar 

  91. Bailey LL, Nehlsen-Cannarella SL, Concepcion W, Jolley WB (1985) Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 254(23):3321–3329

    Article  CAS  PubMed  Google Scholar 

  92. Fishman JA, Scobie L, Takeuchi Y (2012) Xenotransplantation-associated infectious risk: a WHO consultation. Xenotransplantation 19(2):72–81. doi:10.1111/j.1399-3089.2012.00693.x

    Article  PubMed  PubMed Central  Google Scholar 

  93. Postrach J, Bauer A, Schmoeckel M, Reichart B, Brenner P (2012) Heart xenotransplantation in primate models. Methods Mol Biol 885:155–168. doi:10.1007/978-1-61779-845-0_10

    Article  CAS  PubMed  Google Scholar 

  94. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson L, Miller M, Young JB (2012) Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg 144(3):584–603. doi:10.1016/j.jtcvs.2012.05.044; discussion 597–598

    Article  PubMed  PubMed Central  Google Scholar 

  95. Itescu S, John R (2003) Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications. Ann Thorac Surg 75(6):s58–s65

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Critical Care Medicine and Cardiac Surgery, Mazankowski Alberta Heart Institute, University of Alberta, Room 3A6.074, 8440-112 Street, Edmonton, AB, T6G 2B7, Canada

    Gurmeet Singh BMedSc, MD, MSc, FRCSC

Authors
  1. Gurmeet Singh BMedSc, MD, MSc, FRCSC
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gurmeet Singh BMedSc, MD, MSc, FRCSC .

Editor information

Editors and Affiliations

  1. Department of Anaesthesia and Intensive Care Medicine, San Gerardo Hospital, Monza (MB), Italy

    Fabio Sangalli

  2. Department of Health Sciences Medicine, University of Milano-Bicocca, San Gerardo Hospital, Monza (MB), Italy

    Nicolò Patroniti

  3. Health Science Departement, Università Milano Bicocca Facoltà Medicina e Chirurgia, Monza (MB), Italy

    Antonio Pesenti

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Italia

About this chapter

Cite this chapter

Singh, G. (2014). Treatment Options for End-Stage Cardiac Failure. In: Sangalli, F., Patroniti, N., Pesenti, A. (eds) ECMO-Extracorporeal Life Support in Adults. Springer, Milano. https://doi.org/10.1007/978-88-470-5427-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5427-1_19

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5426-4

  • Online ISBN: 978-88-470-5427-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation